$117M venture firm takes flight in Europe

A group of Elan veterans in Ireland have launched a €75 million ($117 million) venture fund for life sciences companies. Fountain Healthcare Partners, based in Dublin, plans to sink anywhere from €500,000 to €7 million in a variety of companies in Europe, with a big focus on Ireland. And the principals expect considerable demand for the cash.

"For companies looking to raise $10 to $15 million to undertake a phase I or phase II study, they really don't have dedicated venture capital funds to raise that money," says partner Aidan King.

- see this release
- read the report in the Wall Street Journal

Suggested Articles

The duo will carry out a phase 2 study of BioNTech’s mRNA cancer immunotherapy in combination with Sanofi and Regeneron’s PD-1 blocker, Libtayo.

Merck was purposely cautious during the start of the pandemic when it came to vaccine development but is now slowly but surely ramping up its efforts

The money will equip AlloVir to embark on a broad clinical development program for a phase 3-ready cell therapy that targets five viruses.